Trial intelligence / Profile preview

ATX-101 for Submental Fat Reduction

NCT00618722Phase 2Completed

Sponsor
Kythera Biopharmaceuticals
Start
Aug 2007
Primary completion
Oct 2008
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of sodium deoxycholate in submental fat, sponsored by Kythera Biopharmaceuticals. Started Aug 2007; status: completed.

02

Drugs

sodium deoxycholate
03

Conditions

submental fat

Beyond the preview

Go deeper on NCT00618722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00618722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call